Etanercept
ENBREL
Tumor Necrosis Factor Blocker
NADAC/unit
$2076.2308
No Shortage
Tier 1: 89.7%
PA Req: 492.4%
Etanercept suppresses inflammation by blocking tumor necrosis factor, used in autoimmune conditions.
vs. brand ENBREL: Generic saves up to -20662% per unit
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
